In a study by Trahair et al., a GLP-1 agonist administered intravenously was shown to reduce the normal increase in superior mesenteric artery (SMA) blood flow in response to oral glucose [23]
The gradual elimination over five weeks
By Ann Czarnik, M.D., FACEP Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health If youre researching GLP-1 weight loss medications , youve probably run into a confusing divide
Studies show that on GLP-1 medications without proper protein intake and resistance exercise, up to 40% of total weight lost can come from muscle, not fat
Multidisciplinary care involving physicians, dietitians, diabetes educators, and mental health professionals optimizes outcomes and addresses the complex pathophysiology of metabolic disease